An official website of the United States government
Support research on technology-based dementia assessment, care and management.
2023 RFA-AG-18-012: Mobile Monitoring of Cognitive Change (U2C) PAR-18-329: Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (R43/R44, Clinical Trial Not Allowed) PAR-18-326: Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) PAS-18-187: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44, Clinical Trial Optional) PAS-18-188: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42, Clinical Trial Optional) PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) PAS-19-317: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) RFA-AG-21-009: Artificial Intelligence and Technology Collaboratories for Aging Research (P30 – Clinical Trial Optional) NOT-AG-20-017: Notice of Special Interest: Digital Technology for Early Detection of Alzheimer’s Disease and Related Dementias RFA-AG-20-050: Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33) RFA-AG-20-051: Low Cost Detection of Cognitive Decline in Clinical Settings (R01) RFA-AG-21-018: Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC) (R24 Clinical Trial Not Allowed) NOT-AG-21-011: Notice of NIH Participation in Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science RFA-AG-21-025: Development of Cost-Effective and Customizable Training and Education Platforms for AD/ADRD Caregivers that Focus on Addressing Financial Management and Legal Planning (R43/R44) 13.I Achieved DN 2017 Dementia Care Summit: 12.1, 12.2, 12.3, and 12.4 2020 Dementia Care Summit: 2.7, 2.8 Relevant 2023 Dementia Care Summit G&Os: 4.3 Research on Care and Caregiver Support Mobile Monitoring of Cognitive Change Edward R. Roybal Centers for Translational Research in the Behavioral and Social Sciences of Aging Collaborative Aging Research Using Technology (CART) MemoryCarePartner Mobile Toolbox Examples of Funded Projects
Launch programs to increase evidence base on effectiveness of technology-based solutions across categories of use (e.g., assessment/monitoring, provision of services, outreach).
Expand evidence to include new technology applications such as sensing and monitoring systems, technology-enhanced assessment programs, EMRs, and robotic applications.
Address cost-effectiveness, usability, challenges and unintended consequences, for populations of various levels of education, health, and computer/technology literacy.
Summary of Key Accomplishments
With co-funding from multiple Institutes, NIA supported a large multi-site research platform called Collaborating Aging Research Using Technology (CART). CART engaged four research sites and diverse research participants to ensure that technologies for aging in place are inclusive, widely applicable, and can be easily integrated into a variety of future research studies. The Artificial Intelligence and Technology Collaboratories, funded since the end of FY 2021, serve as a national resource to promote the development and implementation of artificial intelligence approaches and technology to improve care and health outcomes for older Americans, including persons living with dementia and their care partners. The collaboratories support a several projects in technology-based assessment and care for dementia. For example, in FY 2023-24, more than 60% of the awards made through the three centers under the Artificial Intelligence Collaboratories pertained to technology-based diagnostics for dementia and dementia care. Other NIA-funded projects are developing and sharing mobile tools for cognitive assessment and leveraging electronic health records to explore methods for low-cost detection of cognitive decline. For example, the eRADAR tool, developed with NIA funding, analyzes routinely collected data from electronic health records to detect undiagnosed dementia. eRADAR was recently validated in two real-world health care systems and across racial and ethnic groups.
The key accomplishments summary is current as of July 2024.